SCHEMBL3345967

SCHEMBL3345967

Cc1ccc2cc3c(c4c(c5ccccc53)O4)c3c2c1CC3

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.57
ALDH1A1 P00352 3/20 0.57
MAPT P10636 2/20 0.57
LCK P06239 1/20 0.57
FYN P06241 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
ACHE P22303 1/20 0.57
SLC6A2 P23975 1/20 0.57
AHR P35869 1/20 0.57
CYP2A6 P11509 1/20 0.32
TSHR P16473 1/20 0.32
HPGD P15428 2/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
NPY1R P25929 1/20 0.32
HTT P42858 1/20 0.32
NPY2R P49146 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3345975 0.75 CYP1A2 (0.67) CYP1A2ALDH1A1MAPTLCKFYN
3-Methylcholanthrene SCHEMBL29397062 0.73 ALDH1A1 (1.00) CYP1A2ALDH1A1MAPTLCKFYN
3-Methylcholanthrene SCHEMBL29444145 0.73 ALDH1A1 (1.00) CYP1A2ALDH1A1MAPTLCKFYN
3-Methylcholanthrene SCHEMBL156129 0.73 ALDH1A1 (1.00) CYP1A2ALDH1A1MAPTLCKFYN
3-Methylcholanthrene SCHEMBL27621124 0.72 ALDH1A1 (0.97) CYP1A2ALDH1A1MAPTLCKFYN
3-Methylcholanthrene SCHEMBL2958054 0.72 ALDH1A1 (0.97) CYP1A2ALDH1A1MAPTLCKFYN
SCHEMBL30712558 0.68 ALDH1A1 (0.53) CYP1A2ALDH1A1MAPTLCKFYN
SCHEMBL29093506 0.68 ALDH1A1 (0.53) CYP1A2ALDH1A1MAPTLCKFYN
SCHEMBL5555424 0.63 GPR84 (0.41) CYP1A2ALDH1A1MAPTAHRCYP2A6
SCHEMBL1128910 0.63 ALDH1A1 (0.42) CYP1A2ALDH1A1CYP2A6TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100162416-A1 Multi-stage stem cell carcinogenesis STEMLIFELINE, INC. (US) 2010-06-24 US disclosed